Their conversation centered around the evolving HER2-positive breast cancer treatment paradigm. The experts highlighted that although this disease was once associated with a poor prognosis, targeted ...
For oncology nurses caring for patients with KRAS G12C-mutant metastatic non–small cell lung cancer (NSCLC), new data from the phase 1 KANDLELIT-001 trial (NCT05067283) suggest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results